Sales & Earnings Briefs
This article was originally published in The Tan Sheet
Executive Summary
Pharmacia: Luden's throat drop acquisition, Nicorette launch in Japan spurred an 18% increase in global consumer health sales to $177 mil. in Q3, firm says Oct. 23. U.S. consumer health sales fell 3% to $75 mil. Worldwide Nicorette revenue leaped 51% to $75 mil., while domestic sales dropped 11% to $18 mil. Pharmacia licenses U.S. marketing rights for Nicorette to GlaxoSmithKline. Global and domestic revenue for Rogaine plunged 21% and 26%, respectively, to $26 mil. and $21 mil. Consolidated sales rose 4% to $4.47 bil. and earnings were up 70% to $428 mil., including restructuring and merger-related costs. Without the charges, income increased 24% to $541 mil....